There can be side effects and risks: GLP-1 drugs affect multiple systems (pancreas, kidney, GI tract) and are not without cost or health implications
This article is educational in nature and is not a substitute for medical advice
Testing after pregnancy ensures your restart is personalized to your genetic makeup, not trial-and-error dosing
In contrast to the majority of anti-diabetic compounds, DPP-4 inhibitors do not produce weight gain as a side effect, which is crucial for limiting body weight gain during long-term therapy for diabetes
A large cardiovascular outcome trial in high-risk T2D patients treated with the GLP-1 analog liraglutide (LEADER) demonstrated impressive reductions in CV mortality (22%
To investigate this possibility, untargeted metabolomic profiling was conducted using cervical mucosal samples (generation dataset: EMs: n = 30, controls: n = 30